CA3028031C - Microbial carotenoids affecting gut microbial composition - Google Patents
Microbial carotenoids affecting gut microbial composition Download PDFInfo
- Publication number
- CA3028031C CA3028031C CA3028031A CA3028031A CA3028031C CA 3028031 C CA3028031 C CA 3028031C CA 3028031 A CA3028031 A CA 3028031A CA 3028031 A CA3028031 A CA 3028031A CA 3028031 C CA3028031 C CA 3028031C
- Authority
- CA
- Canada
- Prior art keywords
- microbial
- formula
- gut
- composition
- carotenoid compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Genetics & Genomics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16175832.1 | 2016-06-22 | ||
| EP16175832 | 2016-06-22 | ||
| PCT/EP2017/065348 WO2017220708A1 (en) | 2016-06-22 | 2017-06-22 | Microbial carotenoids affecting gut microbial composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA3028031A1 CA3028031A1 (en) | 2017-12-28 |
| CA3028031C true CA3028031C (en) | 2023-02-28 |
Family
ID=56203217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3028031A Active CA3028031C (en) | 2016-06-22 | 2017-06-22 | Microbial carotenoids affecting gut microbial composition |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11324717B2 (https=) |
| EP (1) | EP3474862B1 (https=) |
| JP (1) | JP6966543B2 (https=) |
| KR (1) | KR102413408B1 (https=) |
| CN (1) | CN109641006B (https=) |
| AU (1) | AU2017281589B2 (https=) |
| BR (1) | BR112018076485A8 (https=) |
| CA (1) | CA3028031C (https=) |
| IL (1) | IL263683B (https=) |
| MX (1) | MX390386B (https=) |
| RU (1) | RU2759600C2 (https=) |
| WO (1) | WO2017220708A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014036182A2 (en) | 2012-08-29 | 2014-03-06 | California Institute Of Technology | Diagnosis and treatment of autism spectrum disorder |
| WO2016069801A1 (en) | 2014-10-30 | 2016-05-06 | California Institute Of Technology | Compositions and methods comprising bacteria for improving behavior in neurodecelopmental disorders |
| EA201790811A1 (ru) | 2014-10-30 | 2017-11-30 | Калифорния Инститьют Оф Текнолоджи | Содержащие бактерии композиции и способы для улучшения видов поведения при нарушениях неврологического развития |
| US20200023018A1 (en) * | 2017-02-07 | 2020-01-23 | California Institute Of Technology | Modulation of gut microbiota in huntington's disease and rett syndrome |
| JP7460531B2 (ja) | 2017-12-05 | 2024-04-02 | バイオピーエルエックス，インコーポレイティド | 微生物感染を防ぐための方法および組成物 |
| AU2019328475B2 (en) * | 2018-08-29 | 2023-02-16 | Dsm Ip Assets B.V. | Formulations for improving gut health |
| CN110283754B (zh) * | 2019-07-11 | 2021-02-02 | 中国科学院北京基因组研究所 | 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群 |
| KR102369996B1 (ko) * | 2020-04-21 | 2022-03-02 | 박선민 | 대사성 질환과 안질환의 예방 및 건강 유지를 위한 장내 미생물 검사 기반 맞춤형 프리바이오틱스 또는 프로바이오틱스 정보 제공방법 |
| CN115606802A (zh) * | 2022-10-21 | 2023-01-17 | 中国农业大学 | 番茄红素在制备修复肠屏障损伤的产品中的应用 |
| WO2025262090A1 (en) | 2024-06-18 | 2025-12-26 | Dsm Ip Assets B.V. | Combination of carotenoids and inulin and uses thereof |
| CN119184223A (zh) * | 2024-10-14 | 2024-12-27 | 元医(杭州)科技有限公司 | 一种基于耐辐射奇球菌素的功能宠物食品及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006083779A2 (en) * | 2005-01-31 | 2006-08-10 | Mylan Laboratories, Inc. | Pharmaceutical composition comprising hydroxylated nebivolol |
| GB0524873D0 (en) * | 2005-12-06 | 2006-01-11 | New Royal Holloway & Bedford | Bacterial production of carotenoids |
| GB201013041D0 (en) | 2010-08-03 | 2010-09-15 | Royal Holloway & New Bedford College | Carotenoids |
-
2017
- 2017-06-22 WO PCT/EP2017/065348 patent/WO2017220708A1/en not_active Ceased
- 2017-06-22 US US16/311,431 patent/US11324717B2/en active Active
- 2017-06-22 BR BR112018076485A patent/BR112018076485A8/pt not_active Application Discontinuation
- 2017-06-22 CN CN201780051160.0A patent/CN109641006B/zh active Active
- 2017-06-22 KR KR1020197001707A patent/KR102413408B1/ko active Active
- 2017-06-22 EP EP17732101.5A patent/EP3474862B1/en active Active
- 2017-06-22 AU AU2017281589A patent/AU2017281589B2/en active Active
- 2017-06-22 CA CA3028031A patent/CA3028031C/en active Active
- 2017-06-22 MX MX2018016118A patent/MX390386B/es unknown
- 2017-06-22 RU RU2019101481A patent/RU2759600C2/ru active
- 2017-06-22 JP JP2019520483A patent/JP6966543B2/ja active Active
-
2018
- 2018-12-12 IL IL263683A patent/IL263683B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX390386B (es) | 2025-03-20 |
| EP3474862A1 (en) | 2019-05-01 |
| BR112018076485A2 (pt) | 2019-04-09 |
| MX2018016118A (es) | 2019-07-08 |
| CN109641006B (zh) | 2022-07-01 |
| KR102413408B1 (ko) | 2022-06-27 |
| WO2017220708A1 (en) | 2017-12-28 |
| BR112018076485A8 (pt) | 2022-12-06 |
| RU2019101481A (ru) | 2020-07-22 |
| JP2019524877A (ja) | 2019-09-05 |
| AU2017281589B2 (en) | 2023-03-23 |
| EP3474862B1 (en) | 2025-10-29 |
| CA3028031A1 (en) | 2017-12-28 |
| IL263683B (en) | 2022-04-01 |
| RU2019101481A3 (https=) | 2020-10-16 |
| CN109641006A (zh) | 2019-04-16 |
| US11324717B2 (en) | 2022-05-10 |
| US20190209516A1 (en) | 2019-07-11 |
| KR20190039687A (ko) | 2019-04-15 |
| RU2759600C2 (ru) | 2021-11-16 |
| IL263683A (en) | 2019-01-31 |
| JP6966543B2 (ja) | 2021-11-17 |
| AU2017281589A1 (en) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3028031C (en) | Microbial carotenoids affecting gut microbial composition | |
| Leonard et al. | Hydroxycinnamic acids on gut microbiota and health | |
| Simó et al. | Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development | |
| Shang et al. | In vitro and in vivo antioxidant activities of inulin | |
| Kulshreshtha et al. | Feed supplementation with red seaweeds, Chondrus crispus and Sarcodiotheca gaudichaudii, affects performance, egg quality, and gut microbiota of layer hens | |
| Macfarlane | Prebiotics in the gastrointestinal tract | |
| Patel et al. | The current trends and future perspectives of prebiotics research: a review | |
| Klinder et al. | Fecal water genotoxicity is predictive of tumor-preventive activities by inulin-like oligofructoses, probiotics (Lactobacillus rhamnosus and Bifidobacterium lactis), and their synbiotic combination | |
| Faghfoori et al. | Cellular and molecular mechanisms of probiotics effects on colorectal cancer | |
| US11260087B2 (en) | Composition for preventing or treating menopause, containing Lactobacillus acidophilus | |
| US12016890B2 (en) | Composition for preventing or treating menopause, containing Lactobacillus intestinalis | |
| dos Reis et al. | Kefir reduces the incidence of pre-neoplastic lesions in an animal model for colorectal cancer | |
| Wang et al. | The effects of dietary ellagic acid supplementation on growth performance, immune response, antioxidant activity, digestive enzyme activities, and intestinal functions in yellow-feathered broilers | |
| Bernabeu et al. | The potential modulation of gut microbiota and oxidative stress by dietary carotenoid pigments | |
| Odun-Ayo et al. | The effect of modified citrus pectin-probiotic on faecal lactobacilli in Balb/c mice | |
| CN121846076A (zh) | 用于在微生物组中生产植物营养素的方法和组合物 | |
| Gulzar et al. | Therapeutic Potential of | |
| Alu’datt et al. | Fermented food-derived bioactive compounds with anticarcinogenic properties: Fermented royal jelly as a novel source for compounds with health benefits | |
| Li et al. | Dietary pectin attenuates Salmonella typhimurium-induced colitis by modulating the TLR2-NF-κB pathway and intestinal microbiota in mice | |
| Park et al. | Combining 2′-fucosyllactose and galacto-oligosaccharides exerts anti-inflammatory effects and promotes gut health | |
| Han et al. | Postbiotics ameliorate DSS-induced colitis in mice by regulating gut microbiota, promoting tryptophan metabolism, and activating AhR/IL-22 signaling pathway | |
| Samanta | Prospective role of prebiotics and probiotics in gut immunity | |
| Fonseca et al. | Function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis (NASH): a systematic review: a systematic review | |
| da FONSECA et al. | The function of nutraceuticals in the intestinal modulation of animals with non-alcoholic steatohepatitis: a systematic review | |
| Borgonovi | Biocompostos de buriti e maracujá: perfil, aplicação em leite fermentado probiótico e modulação da microbiota in vitro |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200608 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250613 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250613 |